SCHEMBL12200632

SCHEMBL12200632

C=CC(=O)NCCCCCCCCCCCCCCCCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ZDHHC20 Q5W0Z9 3/20 1.00
▸ ZDHHC2 Q9UIJ5 3/20 1.00
▸ EPHX1 P07099 9/20 0.59
▸ CASP2 P42575 1/20 0.53
▸ EGFR P00533 1/20 0.50
▸ NAAA Q02083 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ FAAH O00519 1/20 0.47
▸ TGM2 P21980 1/20 0.46
▸ THRA P10827 1/20 0.46
▸ THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8087553 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL1412113 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL14857206 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL10820746 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL719563 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL36870 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL252114 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL16193831 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL232770 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR
SCHEMBL890059 1.00 ZDHHC20 (1.00) ZDHHC20ZDHHC2EPHX1CASP2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4245777-A1 PROCESS FOR SYNTHESIZING POLY(SPERMINE ACRYLAMIDE) AND/OR POLY(SPERMINE ACRYLAMIDE-CO-N-ALKYLACRYLAMIDE) AND THEIR APPLICATION Ludwig-Maximilians-Universität München (DE) 2023-09-20 — — EP disclosed
US-11492432-B2 Resin for nanoimprinting, laminate containing resin for nanoimprinting, printed board containing resin for nanoimprinting, and method for producing nanoimprint substrate JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2022-11-08 — — US disclosed
US-20200223125-A1 RESIN FOR NANOIMPRINTING, LAMINATE CONTAINING RESIN FOR NANOIMPRINTING, PRINTED BOARD CONTAINING RESIN FOR NANOIMPRINTING, AND METHOD FOR PRODUCING NANOIMPRINT SUBSTRATE JAPAN SCIENCE & TECH AGENCY (JP) 2020-07-16 — — US disclosed
US-9891379-B2 Optical fiber coating compositions with acrylic polymers CORNING INCORPORATED (US) 2018-02-13 — — US disclosed
CN-106458735-A Primary coating compositions with reinforcing polymer 康宁股份有限公司 2017-02-22 — — CN disclosed
EP-3102550-A1 PRIMARY COATING COMPOSITIONS WITH REINFORCING POLYMER Corning Incorporated (US) 2016-12-14 — — EP disclosed
US-9505655-B2 Optical fiber coating compositions with non-curable reinforcing agents CORNING INCORPORATED (US) 2016-11-29 — — US disclosed
EP-3092277-A2 OPTICAL FIBRE COATING WITH NON-RADIATION-CURABLE ACRYLIC HARD-SOFT BLOCK COPOLYMER Corning Inc. (US) 2016-11-16 — — EP disclosed
CN-106103376-A Optical fiber coated with non-radiation curable acrylic hard-soft block copolymer 康宁股份有限公司 2016-11-09 — — CN disclosed
US-20160139331-A1 OPTICAL FIBER COATING COMPOSITIONS WITH ACRYLIC POLYMERS CORNING INCORPORATED 2016-05-19 — — US disclosed
US-20110242654-A1 Hardcoat layer-forming composition, optical film, production method of optical film, polarizing plate and image display device FUJIFILM CORPORATION (JP) 2011-10-06 — — US disclosed
US-7906207-B2 Coating composition, optical film, anti-reflection film, polarizing plate, and display unit using them FUJIFILM CORPORATION (JP) 2011-03-15 — — US disclosed
US-20090066898-A1 OPTICALLY-COMPENSATORY SHEET, ELLIPSOIDAL POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2009-03-12 — — US disclosed
US-7462382-B2 Optical compensating sheet, production method thereof, optical film, and polarizing plate and liquid crystal display device using the same FUJIFILM CORPORATION (JP) 2008-12-09 — — US disclosed
US-20080199637-A1 Optical Compensatory Film, Process for Producing the Same, and Polarizing Plate and Liquid Crystal Display Employing the Same FUJIFILM CORPORATION (JP) 2008-08-21 — — US disclosed
US-7311949-B2 Composition, optical film, polarizing plate and liquid crystal display FUJIFILM CORPORATION (JP) 2007-12-25 — — US disclosed
US-20070289497-A1 Coating Composition, Optical Film, Anti-reflection Film, Polarizing Plate, and Display Unit Using Them FUJIFILM CORPORATION (JP) 2007-12-20 — — US disclosed
US-7229695-B2 Low refractive index layer contains a fluoropolymer and an acrylated polysiloxane graft polymer; for use in liquid crystal display units having both a high face figure uniformity and favorable scratch resistance FUJIFILM CORPORATION (JP) 2007-06-12 — — US disclosed
US-20070098920-A1 Optical film, polarizing plate and liquid crystal display FUJIFILM CORPORATION (JP) 2007-05-03 — — US disclosed
US-20070002232-A1 Optical compensation film, polarizing plate and liquid crystal display device FUJI PHOTO FILM CO., LTD. (JP) 2007-01-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090066898-A1 OPTICALLY-COMPENSATORY SHEET, ELLIPSOIDAL POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE SMN1; SMN2, SPOP, RHOXF2 ZDHHC20 3752/4885ZDHHC2 4184/4885EPHX1 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback